Statin shows promise for COPD inflammation in small trial
Disease control
Completed
This completed study tested whether adding a daily statin (atorvastatin 20 mg) to standard treatment for six months could reduce airway inflammation and improve lung function in 80 people with severe COPD. Researchers measured blood markers of inflammation and breathing tests. Th…
Phase: NA • Sponsor: Mohamed Salah El-Sayed • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC